Contact Us
  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Research
  • The Technology
    • Cole Relaxation Frequency
    • Platform Technology
    • Predictive Technology
    • MarginScan™
    • nsCanary™
    • Targeted Drug Delivery
    • Electrical Mammogram
  • Clinical Results
  • Press
  • Contact Us
  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Research
  • The Technology
    • Cole Relaxation Frequency
    • Platform Technology
    • Predictive Technology
    • MarginScan™
    • nsCanary™
    • Targeted Drug Delivery
    • Electrical Mammogram
  • Clinical Results
  • Press
  • Contact Us
  • Home
  • About
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Research
  • The Technology
    • Cole Relaxation Frequency
    • Platform Technology
    • Predictive Technology
    • MarginScan™
    • nsCanary™
    • Targeted Drug Delivery
    • Electrical Mammogram
  • Clinical Results
  • Press
  • Contact Us

Milwaukee Channel 12 Health First

Nov 13, 2014

A local inventor is on the verge of groundbreaking breast cancer technology. https://www.youtube.com/watch?v=cWhf7sZuYiE

NovaScan at the 2014 BIO International Convention in San Diego

Oct 24, 2014

Cancer-scanning device detects residual cancer cells post-surgery—Biotech’s future. Video made by National Science Foundation (NSF). https://www.youtube.com/watch?v=VH_Ib2pVLSg

Next Entries »

Easy to use, ex vivo and in vivo cancer detection that provides instantaneous, highly accurate results, without capital equipment.

 

Address

NovaScan, Inc.
1623 W Fulton St.
Chicago, IL 60612

Contact

Email: cdavis@novascanllc.com
Phone: 312-952-7701

© 2023 NovaScan LLC. All Rights Reserved